OPERATING SEGMENTS (Tables)

3 Months Ended

Mar. 31, 2024

OPERATING SEGMENTS

Schedule of financial information for each of the entity's reportable segments, including the impact of the preceding changes on previously reported full year 2021 net sales and operating income

	December 31, 2023
	2023 Reported					Fixed	2023 Reported
	Valued at 2023				Currency		Valued at 2024
(millions)	Management Rates		Other		Rate Change		Management Rates
Net Sales
Global Industrial		$7,193.1		$407.3		$40.1		$7,640.5
Global Institutional & Specialty		4,994.0		-		20.6		5,014.6
Global Healthcare & Life Sciences		1,576.9		-		30.6		1,607.5
Global Pest Elimination		-		1,061.5		8.7		1,070.2
Other		1,442.3		(1,442.3)		-		-
Corporate		69.1		(26.5)		0.1		42.7
Subtotal at fixed currency rates		15,275.4		-		100.1		15,375.5
Effect of foreign currency translation		44.8				(100.1)		(55.3)
Consolidated reported GAAP net sales		$15,320.2		$-		$-		$15,320.2
Operating Income
Global Industrial		$1,080.7		$39.0		$2.3		$1,122.0
Global Institutional & Specialty		823.0		14.9		3.9		841.8
Global Healthcare & Life Sciences		160.0		(6.7)		7.5		160.8
Global Pest Elimination		-		209.0		1.4		210.4
Other		255.0		(255.0)		-		-
Corporate		(331.7)		(1.2)		0.1		(332.8)
Subtotal at fixed currency rates		1,987.0		-		15.2		2,002.2
Effect of foreign currency translation		5.3		-		(15.2)		(9.9)
Consolidated reported GAAP operating income		$1,992.3		$-		$-		$1,992.3

Schedule of financial information for each of the entity's reportable segments

	First Quarter Ended
	March 31
(millions)	2024		2023
Net Sales
Global Industrial		$1,841.7		$1,808.2
Global Institutional & Specialty		1,270.3		1,131.2
Global Healthcare & Life Sciences		382.9		386.1
Global Pest Elimination		266.8		244.6
Corporate		-		10.7
Subtotal at fixed currency rates		3,761.7		3,580.8
Effect of foreign currency translation		(9.8)		(9.2)
Consolidated reported GAAP net sales		$3,751.9		$3,571.6
Operating Income
Global Industrial		$265.0		$219.8
Global Institutional & Specialty		248.0		130.1
Global Healthcare & Life Sciences		37.0		35.4
Global Pest Elimination		48.8		44.5
Corporate		(79.8)		(77.4)
Subtotal at fixed currency rates		519.0		352.4
Effect of foreign currency translation		(1.1)		(0.8)
Consolidated reported GAAP operating income		$517.9		$351.6